Cargando…
P850: THE HUMORAL AND CELLULAR RESPONSE TO SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA AND PRE-MALIGNANT MONOCLONAL GAMMOPATHIES: IMPACT OF OMICRON VARIANT
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429184/ http://dx.doi.org/10.1097/01.HS9.0000846284.73493.89 |
| _version_ | 1784779358787862528 |
|---|---|
| author | Storti, P. Marchica, V. Vescovini, R. Franceschi, V. Russo, L. Raimondi, V. Toscani, D. Burroughs Garcia, J. Iannozzi, N. T. Dalla Palma, B. Giaimo, M. T. Notarfranchi, L. Donofrio, G. Giuliani, N. |
| author_facet | Storti, P. Marchica, V. Vescovini, R. Franceschi, V. Russo, L. Raimondi, V. Toscani, D. Burroughs Garcia, J. Iannozzi, N. T. Dalla Palma, B. Giaimo, M. T. Notarfranchi, L. Donofrio, G. Giuliani, N. |
| author_sort | Storti, P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429184 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94291842022-08-31 P850: THE HUMORAL AND CELLULAR RESPONSE TO SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA AND PRE-MALIGNANT MONOCLONAL GAMMOPATHIES: IMPACT OF OMICRON VARIANT Storti, P. Marchica, V. Vescovini, R. Franceschi, V. Russo, L. Raimondi, V. Toscani, D. Burroughs Garcia, J. Iannozzi, N. T. Dalla Palma, B. Giaimo, M. T. Notarfranchi, L. Donofrio, G. Giuliani, N. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429184/ http://dx.doi.org/10.1097/01.HS9.0000846284.73493.89 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Storti, P. Marchica, V. Vescovini, R. Franceschi, V. Russo, L. Raimondi, V. Toscani, D. Burroughs Garcia, J. Iannozzi, N. T. Dalla Palma, B. Giaimo, M. T. Notarfranchi, L. Donofrio, G. Giuliani, N. P850: THE HUMORAL AND CELLULAR RESPONSE TO SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA AND PRE-MALIGNANT MONOCLONAL GAMMOPATHIES: IMPACT OF OMICRON VARIANT |
| title | P850: THE HUMORAL AND CELLULAR RESPONSE TO SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA AND PRE-MALIGNANT MONOCLONAL GAMMOPATHIES: IMPACT OF OMICRON VARIANT |
| title_full | P850: THE HUMORAL AND CELLULAR RESPONSE TO SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA AND PRE-MALIGNANT MONOCLONAL GAMMOPATHIES: IMPACT OF OMICRON VARIANT |
| title_fullStr | P850: THE HUMORAL AND CELLULAR RESPONSE TO SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA AND PRE-MALIGNANT MONOCLONAL GAMMOPATHIES: IMPACT OF OMICRON VARIANT |
| title_full_unstemmed | P850: THE HUMORAL AND CELLULAR RESPONSE TO SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA AND PRE-MALIGNANT MONOCLONAL GAMMOPATHIES: IMPACT OF OMICRON VARIANT |
| title_short | P850: THE HUMORAL AND CELLULAR RESPONSE TO SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH MULTIPLE MYELOMA AND PRE-MALIGNANT MONOCLONAL GAMMOPATHIES: IMPACT OF OMICRON VARIANT |
| title_sort | p850: the humoral and cellular response to sars-cov-2 mrna vaccination in patients with multiple myeloma and pre-malignant monoclonal gammopathies: impact of omicron variant |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429184/ http://dx.doi.org/10.1097/01.HS9.0000846284.73493.89 |
| work_keys_str_mv | AT stortip p850thehumoralandcellularresponsetosarscov2mrnavaccinationinpatientswithmultiplemyelomaandpremalignantmonoclonalgammopathiesimpactofomicronvariant AT marchicav p850thehumoralandcellularresponsetosarscov2mrnavaccinationinpatientswithmultiplemyelomaandpremalignantmonoclonalgammopathiesimpactofomicronvariant AT vescovinir p850thehumoralandcellularresponsetosarscov2mrnavaccinationinpatientswithmultiplemyelomaandpremalignantmonoclonalgammopathiesimpactofomicronvariant AT franceschiv p850thehumoralandcellularresponsetosarscov2mrnavaccinationinpatientswithmultiplemyelomaandpremalignantmonoclonalgammopathiesimpactofomicronvariant AT russol p850thehumoralandcellularresponsetosarscov2mrnavaccinationinpatientswithmultiplemyelomaandpremalignantmonoclonalgammopathiesimpactofomicronvariant AT raimondiv p850thehumoralandcellularresponsetosarscov2mrnavaccinationinpatientswithmultiplemyelomaandpremalignantmonoclonalgammopathiesimpactofomicronvariant AT toscanid p850thehumoralandcellularresponsetosarscov2mrnavaccinationinpatientswithmultiplemyelomaandpremalignantmonoclonalgammopathiesimpactofomicronvariant AT burroughsgarciaj p850thehumoralandcellularresponsetosarscov2mrnavaccinationinpatientswithmultiplemyelomaandpremalignantmonoclonalgammopathiesimpactofomicronvariant AT iannozzint p850thehumoralandcellularresponsetosarscov2mrnavaccinationinpatientswithmultiplemyelomaandpremalignantmonoclonalgammopathiesimpactofomicronvariant AT dallapalmab p850thehumoralandcellularresponsetosarscov2mrnavaccinationinpatientswithmultiplemyelomaandpremalignantmonoclonalgammopathiesimpactofomicronvariant AT giaimomt p850thehumoralandcellularresponsetosarscov2mrnavaccinationinpatientswithmultiplemyelomaandpremalignantmonoclonalgammopathiesimpactofomicronvariant AT notarfranchil p850thehumoralandcellularresponsetosarscov2mrnavaccinationinpatientswithmultiplemyelomaandpremalignantmonoclonalgammopathiesimpactofomicronvariant AT donofriog p850thehumoralandcellularresponsetosarscov2mrnavaccinationinpatientswithmultiplemyelomaandpremalignantmonoclonalgammopathiesimpactofomicronvariant AT giulianin p850thehumoralandcellularresponsetosarscov2mrnavaccinationinpatientswithmultiplemyelomaandpremalignantmonoclonalgammopathiesimpactofomicronvariant |